Connect your AI

Intellia Therapeutics NTLA Total Assets

Total Assets at other companies

Ionis PharmaceuticalsIONS

$3.45B+22.6%

ALN

Alnylam PharmaceuticalsALNY

$5.13B+21.7%

CRISPR TherapeuticsCRSP

$2.73B+25.8%

Beam TherapeuticsBEAM

$1.48B+0.9%

Iovance Biotherapeutics, Inc.IOVA

$925.67M-4.2%

Viridian Therapeutics, Inc.VRDN

$789.02M+19.4%

Other financials

Income statement

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Cash flow

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

Market cap$2.13B+106%

Enterprise value$2.08B+100%

P/S32.2×+9.5×

Profitability

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Intellia Therapeutics's total assets?: Intellia Therapeutics (NTLA) reported total assets of $758.78M in Q1 2026.
How has Intellia Therapeutics's total assets changed year-over-year?: Intellia Therapeutics's total assets decreased by 23.1% year-over-year, from $986.16M to $758.78M.
What is the long-term trend for Intellia Therapeutics's total assets?: Over 5 years (2020 to 2025), Intellia Therapeutics's total assets has grown at a 4.5% compound annual growth rate (CAGR), from $676.32M to $842.13M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.